![]() |


![]() |
Create Name: | |
Description: |
![]() |
Save what matters to you |
{{ loginError }} |
Sign in with your RGD account |
Create New Account | Recover Password |
Analyze GeneStrainQTL List |
![]() Gene Annotator (Functional Annotation) unavailable |
![]() Gene Annotator (Annotation Distribution) unavailable |
![]() Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
![]() InterViewer (Protein-Protein Interactions) unavailable |
![]() Gviewer (Genome Viewer) unavailable |
![]() Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
![]() Gene Annotator (Annotation Comparison) unavailable |
![]() OLGA (Gene List Generator) unavailable |
![]() |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
![]() MOET (Multi-Ontology Enrichement) unavailable |
![]() GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
![]() Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1318046 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RPS6KA5 mRNA | CTD | PMID:22079256 | 17beta-estradiol | multiple interactions | ISO | RGD:1318046 | 6480464 | [Progesterone co-treated with Estradiol] results in decreased expression of RPS6KA5 mRNA | CTD | PMID:17404688 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1318047 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of RPS6KA5 mRNA | CTD | PMID:19933214 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1318047 | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [RPS6KA5 protein binds to CYP1A1 enhancer] | CTD | PMID:24519526 | 3,3',5,5'-tetrabromobisphenol A | decreases expression | ISO | RGD:1318047 | 6480464 | tetrabromobisphenol A results in decreased expression of RPS6KA5 mRNA | CTD | PMID:25172293 | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | RGD:1318047 | 6480464 | N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of RPS6KA5 mRNA | CTD | PMID:26251327 | 3,4-methylenedioxymethamphetamine | decreases methylation | ISO | RGD:1318047 | 6480464 | N-Methyl-3, 4-methylenedioxyamphetamine results in decreased methylation of RPS6KA5 promoter | CTD | PMID:26251327 | 4,4'-diaminodiphenylmethane | increases expression | ISO | RGD:1318047 | 6480464 | 4, 4'-diaminodiphenylmethane results in increased expression of RPS6KA5 mRNA | CTD | PMID:18648102 | 4-hydroxyphenyl retinamide | decreases expression | ISO | RGD:1318047 | 6480464 | Fenretinide results in decreased expression of RPS6KA5 mRNA | CTD | PMID:28973697 | 5-(1,4-diazepane-1-sulfonyl)isoquinoline | decreases activity | ISO | RGD:1318046 | 6480464 | fasudil results in decreased activity of RPS6KA5 protein | CTD | PMID:10998351 | arsenite(3-) | increases activity | ISO | RGD:1318047 | 6480464 | arsenite results in increased activity of RPS6KA5 protein | CTD | PMID:11689710 | benzo[a]pyrene | decreases expression | ISO | RGD:1318047 | 6480464 | Benzo(a)pyrene results in decreased expression of RPS6KA5 mRNA | CTD | PMID:22228805 | benzo[a]pyrene | multiple interactions | EXP | | 6480464 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Benzo(a)pyrene promotes the reaction [TNF protein results in increased expression of RPS6KA5 protein modified form]], Benzo(a)pyrene promotes the reaction [TNF protein results in increased expression of RPS6KA5 protein modified form] | CTD | PMID:25233930 | bis(2-chloroethyl) sulfide | decreases expression | ISO | RGD:1318047 | 6480464 | Mustard Gas results in decreased expression of RPS6KA5 mRNA | CTD | PMID:18955075 | bis(2-chloroethyl) sulfide | increases phosphorylation | ISO | RGD:1318047 | 6480464 | Mustard Gas results in increased phosphorylation of RPS6KA5 protein | CTD | PMID:18200059 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of RPS6KA5 mRNA | CTD | PMID:25181051 | calcitriol | decreases expression | ISO | RGD:1318046 | 6480464 | Calcitriol results in decreased expression of RPS6KA5 mRNA | CTD | PMID:16002434 | chloroprene | increases expression | EXP | | 6480464 | Chloroprene results in increased expression of RPS6KA5 mRNA | CTD | PMID:23125180 | cocaine | increases expression | EXP | | 6480464 | Cocaine results in increased expression of RPS6KA5 mRNA, Cocaine results in increased expression of RPS6KA5 protein | CTD | PMID:17898221, PMID:25100957 | cocaine | affects response to substance | ISO | RGD:1318047 | 6480464 | RPS6KA5 affects the susceptibility to Cocaine | CTD | PMID:16339038 | cocaine | increases activity | ISO | RGD:1318047 | 6480464 | Cocaine results in increased activity of RPS6KA5 protein | CTD | PMID:16339038 | cocaine | multiple interactions | ISO | RGD:1318047 | 6480464 | Cocaine results in increased phosphorylation of and results in increased activity of RPS6KA5 protein, SL 327 inhibits the reaction [Cocaine results in increased phosphorylation of and results in increased activity of RPS6KA5 protein] | CTD | PMID:16339038 | cyclosporin A | increases expression | ISO | RGD:1318046 | 6480464 | Cyclosporine results in increased expression of RPS6KA5 mRNA | CTD | PMID:20106945 | deoxynivalenol | increases phosphorylation | ISO | RGD:1318047 | 6480464 | deoxynivalenol results in increased phosphorylation of RPS6KA5 protein | CTD | PMID:16424113 | diclofenac | decreases expression | ISO | RGD:1318047 | 6480464 | Diclofenac results in decreased expression of RPS6KA5 mRNA | CTD | PMID:26934552 | dorsomorphin | multiple interactions | ISO | RGD:1318046 | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RPS6KA5 mRNA | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | RGD:1318046 | 6480464 | Doxorubicin results in decreased expression of RPS6KA5 mRNA | CTD | PMID:29803840 | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of RPS6KA5 mRNA | CTD | PMID:29391264 | ethyl methanesulfonate | increases expression | ISO | RGD:1318046 | 6480464 | Ethyl Methanesulfonate results in increased expression of RPS6KA5 mRNA | CTD | PMID:23649840 | fasudil hydrochloride | decreases activity | ISO | RGD:1318046 | 6480464 | fasudil results in decreased activity of RPS6KA5 protein | CTD | PMID:10998351 | formaldehyde | increases expression | ISO | RGD:1318046 | 6480464 | Formaldehyde results in increased expression of RPS6KA5 mRNA | CTD | PMID:23649840 | gallic acid | multiple interactions | ISO | RGD:1318046 | 6480464 | Gallic Acid inhibits the reaction [TNF protein results in increased phosphorylation of RPS6KA5 protein] | CTD | PMID:21420233 | hexane | decreases methylation | EXP | | 6480464 | n-hexane results in decreased methylation of RPS6KA5 promoter | CTD | PMID:23740543 | hydralazine | multiple interactions | ISO | RGD:1318046 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of RPS6KA5 mRNA | CTD | PMID:17183730 | hydrogen peroxide | increases activity | ISO | RGD:1318047 | 6480464 | Hydrogen Peroxide results in increased activity of RPS6KA5 protein | CTD | PMID:11689710 | MeIQx | increases expression | ISO | RGD:1318046 | 6480464 | 2-amino-3 more ... | CTD | PMID:20816883 | methyl methanesulfonate | increases expression | ISO | RGD:1318046 | 6480464 | Methyl Methanesulfonate results in increased expression of RPS6KA5 mRNA | CTD | PMID:23649840 | mifepristone | decreases expression | EXP | | 6480464 | Mifepristone results in decreased expression of RPS6KA5 mRNA | CTD | PMID:25972201 | ML-7 | decreases activity | ISO | RGD:1318046 | 6480464 | ML 7 results in decreased activity of RPS6KA5 protein | CTD | PMID:12534346 | N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide | decreases activity | ISO | RGD:1318046 | 6480464 | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide results in decreased activity of RPS6KA5 protein | CTD | PMID:10998351, PMID:18377872 | N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide | decreases activity | EXP | | 6480464 | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide results in decreased activity of RPS6KA5 protein | CTD | PMID:15522277 | nickel sulfate | increases expression | ISO | RGD:1318046 | 6480464 | nickel sulfate results in increased expression of RPS6KA5 mRNA | CTD | PMID:22714537 | obeticholic acid | decreases expression | ISO | RGD:1318046 | 6480464 | obeticholic acid results in decreased expression of RPS6KA5 mRNA | CTD | PMID:27939613 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of RPS6KA5 mRNA | CTD | PMID:25729387 | oxidopamine | multiple interactions | ISO | RGD:1318047 | 6480464 | [benserazide, levodopa drug combination co-treated with Oxidopamine] results in increased phosphorylation of RPS6KA5 protein more ... | CTD | PMID:17596448, PMID:19187092 | paraquat | increases expression | ISO | RGD:1318047 | 6480464 | Paraquat results in increased expression of RPS6KA5 mRNA | CTD | PMID:28012437 | phenylephrine | multiple interactions | EXP | | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of RPS6KA5 protein] more ... | CTD | PMID:15522277, PMID:19002563 | pirinixic acid | multiple interactions | ISO | RGD:1318047 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of RPS6KA5 mRNA | CTD | PMID:19710929 | potassium chromate | multiple interactions | ISO | RGD:1318046 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RPS6KA5 mRNA | CTD | PMID:22079256 | potassium chromate | decreases expression | ISO | RGD:1318046 | 6480464 | potassium chromate(VI) results in decreased expression of RPS6KA5 mRNA | CTD | PMID:22079256 | progesterone | multiple interactions | ISO | RGD:1318046 | 6480464 | [Progesterone co-treated with Estradiol] results in decreased expression of RPS6KA5 mRNA | CTD | PMID:17404688 | quercetin | increases phosphorylation | ISO | RGD:1318046 | 6480464 | Quercetin results in increased phosphorylation of RPS6KA5 protein | CTD | PMID:18377872 | quercetin | multiple interactions | ISO | RGD:1318046 | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Quercetin results in increased phosphorylation of RPS6KA5 protein] | CTD | PMID:18377872 | Ro 31-8220 | decreases activity | EXP | | 6480464 | Ro 31-8220 results in decreased activity of RPS6KA5 protein | CTD | PMID:15522277 | SB 203580 | multiple interactions | ISO | RGD:1318046 | 6480464 | [U 0126 co-treated with SB 203580] inhibits the reaction [sodium arsenite results in increased activity of RPS6KA5 protein], SB 203580 inhibits the reaction [sodium arsenite results in increased activity of RPS6KA5 protein] | CTD | PMID:12547826 | SB 203580 | multiple interactions | EXP | | 6480464 | SB 203580 inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of RPS6KA5 protein] | CTD | PMID:15522277 | SB 431542 | multiple interactions | ISO | RGD:1318046 | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RPS6KA5 mRNA | CTD | PMID:27188386 | SCH 23390 | multiple interactions | ISO | RGD:1318047 | 6480464 | SCH 23390 inhibits the reaction [[Oxidopamine co-treated with Levodopa] results in increased expression of RPS6KA5 protein] | CTD | PMID:19187092 | silicon dioxide | increases expression | ISO | RGD:1318046 | 6480464 | Silicon Dioxide analog results in increased expression of RPS6KA5 mRNA | CTD | PMID:25895662 | silicon dioxide | decreases expression | ISO | RGD:1318047 | 6480464 | Silicon Dioxide results in decreased expression of RPS6KA5 mRNA | CTD | PMID:29203145 | silver atom | decreases expression | ISO | RGD:1318047 | 6480464 | Silver results in decreased expression of RPS6KA5 mRNA | CTD | PMID:27131904 | silver(0) | decreases expression | ISO | RGD:1318047 | 6480464 | Silver results in decreased expression of RPS6KA5 mRNA | CTD | PMID:27131904 | SL-327 | multiple interactions | ISO | RGD:1318047 | 6480464 | SL 327 inhibits the reaction [[benserazide, levodopa drug combination co-treated with Oxidopamine] results in increased phosphorylation of RPS6KA5 protein], SL 327 inhibits the reaction [Cocaine results in increased phosphorylation of and results in increased activity of RPS6KA5 protein] | CTD | PMID:16339038, PMID:17596448 | sodium arsenite | multiple interactions | ISO | RGD:1318046 | 6480464 | [U 0126 co-treated with SB 203580] inhibits the reaction [sodium arsenite results in increased activity of RPS6KA5 protein] more ... | CTD | PMID:12547826 | sodium arsenite | decreases expression | ISO | RGD:1318046 | 6480464 | sodium arsenite results in decreased expression of RPS6KA5 mRNA | CTD | PMID:28595984 | sodium arsenite | increases activity | ISO | RGD:1318046 | 6480464 | sodium arsenite results in increased activity of RPS6KA5 protein | CTD | PMID:12547826 | succimer | multiple interactions | ISO | RGD:1318047 | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RPS6KA5 mRNA | CTD | PMID:21641980 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of RPS6KA5 mRNA | CTD | PMID:25729387 | topotecan | decreases expression | EXP | | 6480464 | Topotecan results in decreased expression of RPS6KA5 mRNA | CTD | PMID:25729387 | trichostatin A | increases expression | ISO | RGD:1318046 | 6480464 | trichostatin A results in increased expression of RPS6KA5 mRNA | CTD | PMID:24935251, PMID:26272509 | trichostatin A | multiple interactions | ISO | RGD:1318046 | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RPS6KA5 mRNA | CTD | PMID:27188386 | urethane | increases expression | ISO | RGD:1318046 | 6480464 | Urethane results in increased expression of RPS6KA5 mRNA | CTD | PMID:28818685 | valproic acid | multiple interactions | ISO | RGD:1318046 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of RPS6KA5 mRNA | CTD | PMID:17183730 | valproic acid | decreases methylation | ISO | RGD:1318046 | 6480464 | Valproic Acid results in decreased methylation of RPS6KA5 gene | CTD | PMID:28853863 more ... | valproic acid | increases expression | ISO | RGD:1318046 | 6480464 | Valproic Acid results in increased expression of RPS6KA5 mRNA | CTD | PMID:29154799 | valproic acid | decreases expression | ISO | RGD:1318046 | 6480464 | Valproic Acid results in decreased expression of RPS6KA5 mRNA | CTD | PMID:23179753, PMID:28001369 | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of RPS6KA5 mRNA | CTD | PMID:18042343 | vinclozolin | affects expression | EXP | | 6480464 | vinclozolin affects the expression of RPS6KA5 mRNA | CTD | PMID:19015723 | Y-27632 | decreases activity | ISO | RGD:1318046 | 6480464 | Y 27632 results in decreased activity of RPS6KA5 protein | CTD | PMID:10998351 | |
|
|
|
|
|
|
|
|
|
|
1. | Gaestel M Nat Rev Mol Cell Biol. 2006 Feb;7(2):120-30. |
2. | Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27. |
3. | MGD data from the GO Consortium |
4. | Pipeline to import KEGG annotations from KEGG into RGD |
5. | RGD automated data pipeline |
6. | RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations |
7. | RGD automated import pipeline for gene-chemical interactions |
PubMed | 9687510 9873047 11994045 12628924 12763138 12773393 15010469 15893597 16531007 18385332 18511904 19197368 20018936 21493629 22004609 22082260 23065332 24142296 24349124 24352802 30919247 |
Rps6ka5 (Rattus norvegicus - Norway rat) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RPS6KA5 (Homo sapiens - human) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rps6ka5 (Mus musculus - house mouse) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rps6ka5 (Chinchilla lanigera - long-tailed chinchilla) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RPS6KA5 (Pan paniscus - bonobo/pygmy chimpanzee) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RPS6KA5 (Canis lupus familiaris - dog) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rps6ka5 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RPS6KA5 (Sus scrofa - pig) |
|
BE108505 |
|
|||||||||||||||||||||||||||||||||||
RH138282 |
|
|||||||||||||||||||||||||||||||||||
AU049990 |
|
The following QTLs overlap with this region. | ![]() | Full Report | ![]() | CSV | ![]() | TAB | ![]() | Printer | ![]() | Gviewer |
The detailed report is available here: | ![]() | Full Report | ![]() | CSV | ![]() | TAB | ![]() | Printer |
miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/). For more information about miRGate, see PMID:25858286 or access the full paper here. |
testis | heart | brain | ovary | uterus | skeletal muscle tissue | colon | gastrocnemius | forebrain | hindbrain | lung | spleen | liver | kidney | adrenal gland | thymus | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
High | ||||||||||||||||
Medium | 10 | 11 | 8 | 4 | 1 | 26 | 21 | 10 | 8 | 8 | 8 | |||||
Low | 12 | 43 | 12 | 7 | 3 | 3 | 7 | 4 | 1 | 3 | 41 | 35 | ||||
Below cutoff |
RefSeq Transcripts | NM_001108048 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
XM_006240437 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_006240438 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_017594167 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_017594168 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_017594169 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_017594170 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XM_017594171 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
GenBank Nucleotide | AABR07065365 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
AABR07065366 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AAHX01046162 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AAHX01046163 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AAHX01046164 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AAHX01046165 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AAHX01046166 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
CH473982 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
RefSeq Acc Id: | NM_001108048 ⟹ NP_001101518 | ||||||||||||||||||||||||
RefSeq Status: | PROVISIONAL | ||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||
Sequence: |
CCGCGGCCAGAGCGGGAAAGAGACTCGCCTCAGTGTCGGAGTTGTGGCGCTGCGGCAGCTTGGChide sequence |
RefSeq Acc Id: | XM_006240437 ⟹ XP_006240499 | ||||||||||||||
RefSeq Status: | |||||||||||||||
Type: | CODING | ||||||||||||||
Position: |
|
||||||||||||||
Sequence: |
TGCGCCGTACTAGCGGTGCCCGCTGAGGGGAGGAGGCGGAGGAGCTCCGCGGCCAGAGCGGGAAhide sequence |
RefSeq Acc Id: | XM_006240438 ⟹ XP_006240500 | ||||||||||||||
RefSeq Status: | |||||||||||||||
Type: | CODING | ||||||||||||||
Position: |
|
||||||||||||||
Sequence: |
TGCGCCGTACTAGCGGTGCCCGCTGAGGGGAGGAGGCGGAGGAGCTCCGCGGCCAGAGCGGGAAhide sequence |
RefSeq Acc Id: | XM_017594167 ⟹ XP_017449656 | |||||||||
RefSeq Status: | ||||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
GTCCTGAGACAGTGTCAGAATTTTAGACAAGTCATAACTATTCAAGAAGTTAGTCACAAGAAAChide sequence |
RefSeq Acc Id: | XM_017594168 ⟹ XP_017449657 | |||||||||
RefSeq Status: | ||||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
CCGGCCGGGCCAGCTTCGGAGGCGCGCTTGAGAGCCGGCTTGGGCGCGCGCGCAGGCCAAGAGGhide sequence |
RefSeq Acc Id: | XM_017594169 ⟹ XP_017449658 | |||||||||
RefSeq Status: | ||||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
TTAGTTGTTGTTCTGTTGCTGTGAAGAGACACCGTGACCAAGGCAACACTTATCAAAGAAAGCAhide sequence |
RefSeq Acc Id: | XM_017594170 ⟹ XP_017449659 | |||||||||
RefSeq Status: | ||||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
AATGCCATAAAAATAATCTCCTGTAGGTTTCCAGAGCATTACTCCTTCTGTTCATTCCTAGCAAhide sequence |
RefSeq Acc Id: | XM_017594171 ⟹ XP_017449660 | |||||||||
RefSeq Status: | ||||||||||
Type: | CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
AATGCCATAAAAATAATCTCCTGTAGGTTTCCAGAGCATTACTCCTTCTGTTCATTCCTAGCAAhide sequence |
Protein RefSeqs | NP_001101518 | (Get FASTA) | NCBI Sequence Viewer |
XP_006240499 | (Get FASTA) | NCBI Sequence Viewer | |
XP_006240500 | (Get FASTA) | NCBI Sequence Viewer | |
XP_017449656 | (Get FASTA) | NCBI Sequence Viewer | |
XP_017449657 | (Get FASTA) | NCBI Sequence Viewer | |
XP_017449658 | (Get FASTA) | NCBI Sequence Viewer | |
XP_017449659 | (Get FASTA) | NCBI Sequence Viewer | |
XP_017449660 | (Get FASTA) | NCBI Sequence Viewer | |
GenBank Protein | EDL81720 | (Get FASTA) | NCBI Sequence Viewer |
RefSeq Acc Id: | NP_001101518 ⟸ NM_001108048 |
- UniProtKB: | D3ZY17 (UniProtKB/TrEMBL) |
- Sequence: |
MEGEGGGSGGAGTSGDSGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLhide sequence |
RefSeq Acc Id: | XP_006240500 ⟸ XM_006240438 |
- Peptide Label: | isoform X2 |
- Sequence: |
MEGEGGGSGGAGTSGDSGDGGEQLLTVKHELRTAYGKVFLVRKISGHDAGKLYAMKVLKKATIVhide sequence |
RefSeq Acc Id: | XP_006240499 ⟸ XM_006240437 |
- Peptide Label: | isoform X1 |
- UniProtKB: | A0A0G2K366 (UniProtKB/TrEMBL) |
- Sequence: |
MEGEGGGSGGAGTSGDSGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLhide sequence |
RefSeq Acc Id: | XP_017449657 ⟸ XM_017594168 |
- Peptide Label: | isoform X3 |
- Sequence: |
MKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLhide sequence |
RefSeq Acc Id: | XP_017449656 ⟸ XM_017594167 |
- Peptide Label: | isoform X3 |
- Sequence: |
MKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLhide sequence |
RefSeq Acc Id: | XP_017449658 ⟸ XM_017594169 |
- Peptide Label: | isoform X3 |
- Sequence: |
MKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLhide sequence |
RefSeq Acc Id: | XP_017449660 ⟸ XM_017594171 |
- Peptide Label: | isoform X4 |
- Sequence: |
MSSVAKDLLQRLLMKDPKKRLGCGPRDAEEIKEHLFFEKINWDDLAAKKVPAPFKPVIRDELDVhide sequence |
RefSeq Acc Id: | XP_017449659 ⟸ XM_017594170 |
- Peptide Label: | isoform X4 |
- Sequence: |
MSSVAKDLLQRLLMKDPKKRLGCGPRDAEEIKEHLFFEKINWDDLAAKKVPAPFKPVIRDELDVhide sequence |
RGD ID: | 13694783 | |||||||||
Promoter ID: | EPDNEW_R5300 | |||||||||
Type: | single initiation site | |||||||||
Name: | Rps6ka5_1 | |||||||||
Description: | ribosomal protein S6 kinase A5 | |||||||||
SO ACC ID: | SO:0000170 | |||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | |||||||||
Experiment Methods: | Single-end sequencing. | |||||||||
Position: |
|
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
Chromosome | Start Pos | End Pos | Reference Nucleotide | Variant Nucleotide | Variant Type | Strain |
6 | 124651968 | 124651969 | A | C | snv | SR/JrHsd (RGD) |
Database | Acc Id | Source(s) |
AGR Gene | RGD:1308336 | AgrOrtholog |
Ensembl Genes | ENSRNOG00000004362 | ENTREZGENE, UniProtKB/TrEMBL |
Ensembl Protein | ENSRNOP00000063163 | ENTREZGENE, UniProtKB/TrEMBL |
ENSRNOP00000072518 | ENTREZGENE, UniProtKB/TrEMBL | |
Ensembl Transcript | ENSRNOT00000064716 | ENTREZGENE, UniProtKB/TrEMBL |
ENSRNOT00000091693 | ENTREZGENE, UniProtKB/TrEMBL | |
InterPro | AGC-kinase_C | UniProtKB/TrEMBL |
Kinase-like_dom | UniProtKB/TrEMBL | |
Pkinase_C | UniProtKB/TrEMBL | |
Prot_kinase_cat_dom | UniProtKB/TrEMBL | |
Protein_kinase_ATP_BS | UniProtKB/TrEMBL | |
Ribosomal_S6_kinase_II | UniProtKB/TrEMBL | |
Ser/Thr_prot_kinase_AS | UniProtKB/TrEMBL | |
KEGG Report | rno:314384 | UniProtKB/TrEMBL |
NCBI Gene | 314384 | ENTREZGENE |
Pfam | Pkinase | UniProtKB/TrEMBL |
Pkinase_C | UniProtKB/TrEMBL | |
PhenoGen | Rps6ka5 | PhenoGen |
PIRSF | Ribsml_S6_kin_2 | UniProtKB/TrEMBL |
PROSITE | AGC_KINASE_CTER | UniProtKB/TrEMBL |
PROTEIN_KINASE_ATP | UniProtKB/TrEMBL | |
PROTEIN_KINASE_DOM | UniProtKB/TrEMBL | |
PROTEIN_KINASE_ST | UniProtKB/TrEMBL | |
SMART | S_TK_X | UniProtKB/TrEMBL |
S_TKc | UniProtKB/TrEMBL | |
Superfamily-SCOP | Kinase_like | UniProtKB/TrEMBL |
UniGene | Rn.8940 | ENTREZGENE |
UniProt | A0A0G2K366 | ENTREZGENE, UniProtKB/TrEMBL |
D3ZY17 | ENTREZGENE, UniProtKB/TrEMBL |
Date | Current Symbol | Current Name | Previous Symbol | Previous Name | Description | Reference | Status |
---|---|---|---|---|---|---|---|
2016-04-04 | Rps6ka5 | ribosomal protein S6 kinase A5 | Rps6ka5 | ribosomal protein S6 kinase, polypeptide 5 | Nomenclature updated to reflect human and mouse nomenclature | 1299863 | APPROVED |
2008-04-30 | Rps6ka5 | ribosomal protein S6 kinase, polypeptide 5 | Rps6ka5_predicted | ribosomal protein S6 kinase, polypeptide 5 (predicted) | 'predicted' is removed | 2292626 | APPROVED |
2005-01-12 | Rps6ka5_predicted | ribosomal protein S6 kinase, polypeptide 5 (predicted) | Symbol and Name status set to approved | 70820 | APPROVED |
![]() |
More on Rps6ka5 | |
![]() |
Alliance Gene |
![]() |
NCBI Gene |
![]() |
Ensembl Gene |
![]() |
JBrowse: rn5 rn6 |
![]() |
NCBI Genome Data Viewer |
CRRD Object Information | |
CRRD ID: | 1308336 |
Created: | 2005-01-12 |
Species: | Rattus norvegicus |
Last Modified: | 2019-11-27 |
Status: | ACTIVE |
![]() |
![]() |
![]() |
![]() |
RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.